The presence of CD28lo KLRG1hi CD127lo HLA-DRhi CD8+ T cells prior to detection of viremia may serve as additional key biomarker for predicting which patients are likely to resist or develop CMV infection, potentially guiding early care and treatment strategies. This evidence concerns the gene CD8A and cytomegalovirus infection.